Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

The prognostic significance of vasohibin-1 expression in patients with prostate cancer.

Kosaka T, Miyazaki Y, Miyajima A, Mikami S, Hayashi Y, Tanaka N, Nagata H, Kikuchi E, Nakagawa K, Okada Y, Sato Y, Oya M.

Br J Cancer. 2013 May 28;108(10):2123-9. doi: 10.1038/bjc.2013.169. Epub 2013 Apr 16.

2.

The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma.

Miyazaki Y, Kosaka T, Mikami S, Kikuchi E, Tanaka N, Maeda T, Ishida M, Miyajima A, Nakagawa K, Okada Y, Sato Y, Oya M.

Clin Cancer Res. 2012 Aug 1;18(15):4145-53. doi: 10.1158/1078-0432.CCR-12-0073. Epub 2012 Jun 6.

3.

The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.

Murakami K, Kasajima A, Kawagishi N, Sekiguchi S, Fujishima F, Watanabe M, Sato Y, Ohuchi N, Sasano H.

Hum Pathol. 2014 Mar;45(3):589-97. doi: 10.1016/j.humpath.2013.10.028. Epub 2013 Nov 6.

PMID:
24444468
4.

Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma.

Kanomata N, Sato Y, Miyaji Y, Nagai A, Moriya T.

J Clin Pathol. 2013 Jul;66(7):613-9. doi: 10.1136/jclinpath-2013-201444. Epub 2013 Mar 29.

PMID:
23543668
5.
6.

CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy.

Bettencourt MC, Bauer JJ, Sesterhenn IA, Connelly RR, Moul JW.

J Urol. 1998 Aug;160(2):459-65.

PMID:
9679898
7.

Reduced expression of vasohibin-1 is associated with clinicopathological features in renal cell carcinoma.

Zhao G, Yang Y, Tang Y, Han R, Sun Y.

Med Oncol. 2012 Dec;29(5):3325-34. doi: 10.1007/s12032-012-0313-x. Epub 2012 Aug 3.

PMID:
22865127
8.

Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.

Miyata Y, Mitsunari K, Asai A, Takehara K, Mochizuki Y, Sakai H.

Prostate. 2015 Jan;75(1):84-91. doi: 10.1002/pros.22894. Epub 2014 Oct 13.

9.

Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis.

Kitajima T, Toiyama Y, Tanaka K, Saigusa S, Kobayashi M, Inoue Y, Mohri Y, Kusunoki M.

Anticancer Res. 2014 Oct;34(10):5321-9.

PMID:
25275025
10.

Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31.

de la Taille A, Katz AE, Bagiella E, Buttyan R, Sharir S, Olsson CA, Burchardt T, Ennis RD, Rubin MA.

Am J Clin Pathol. 2000 Apr;113(4):555-62.

PMID:
10761458
11.

Increased vasohibin-1 expression is associated with metastasis and poor prognosis of renal cell carcinoma patients.

Mikami S, Oya M, Kosaka T, Mizuno R, Miyazaki Y, Sato Y, Okada Y.

Lab Invest. 2017 Mar 13. doi: 10.1038/labinvest.2017.26. [Epub ahead of print]

PMID:
28287633
12.

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.

BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.

13.

The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade.

Gyftopoulos K, Vourda K, Sakellaropoulos G, Perimenis P, Athanasopoulos A, Papadaki E.

Urol Int. 2011;87(4):464-9. doi: 10.1159/000329289. Epub 2011 Sep 10.

PMID:
21912077
14.

Independent prognostic importance of microvessel density in clinically localized prostate cancer.

Halvorsen OJ, Haukaas S, Høisaeter PA, Akslen LA.

Anticancer Res. 2000 Sep-Oct;20(5C):3791-9.

PMID:
11268456
15.

Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the disease.

Di Lorenzo G, De Placido S, Autorino R, De Laurentiis M, Mignogna C, D'Armiento M, Tortora G, De Rosa G, D'Armiento M, De Sio M, Bianco AR, D'Armiento FP.

Prostate Cancer Prostatic Dis. 2005;8(1):54-9.

PMID:
15655565
16.
17.

Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell Carcinoma.

Torii C, Hida Y, Shindoh M, Akiyama K, Ohga N, Maishi N, Ohiro Y, Ono M, Totsuka Y, Kitagawa Y, Tei K, Sato Y, Hida K.

Anticancer Res. 2017 Mar;37(3):1219-1225.

PMID:
28314285
18.

Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer.

Wang WQ, Liu L, Xu HX, Luo GP, Chen T, Wu CT, Xu YF, Xu J, Liu C, Zhang B, Long J, Tang ZY, Yu XJ.

PLoS One. 2013 Aug 5;8(8):e71189. doi: 10.1371/journal.pone.0071189. Print 2013.

19.

Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by microvessel density after immunohistochemical staining for CD34.

Ajili F, Kacem M, Tounsi H, Darouiche A, Enayfer E, Chebi M, Manai M, Boubaker S.

Ultrastruct Pathol. 2012 Oct;36(5):336-42. doi: 10.3109/01913123.2012.672847. Epub 2012 May 10.

PMID:
22574784
20.

Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients.

Mazzucchelli R, Montironi R, Santinelli A, Lucarini G, Pugnaloni A, Biagini G.

Prostate. 2000 Sep 15;45(1):72-9.

PMID:
10960845

Supplemental Content

Support Center